248 related articles for article (PubMed ID: 3876835)
1. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
2. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
[TBL] [Abstract][Full Text] [Related]
3. B-lymphocytes, thymocytes and platelets accumulate high dATP levels in simulated ADA deficiency.
Goday A; Simmonds HA; Fairbanks LD; Morris GS
Adv Exp Med Biol; 1986; 195 Pt A():515-20. PubMed ID: 3487922
[No Abstract] [Full Text] [Related]
4. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response?
Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ
Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053
[TBL] [Abstract][Full Text] [Related]
5. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of deoxyadenosine-induced catabolism of adenine ribonucleotides in adenosine deaminase-inhibited human T lymphoblastoid cells.
Bagnara AS; Hershfield MS
Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2673-7. PubMed ID: 6283540
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes.
Simmonds HA; Goday A; Morris GS; Brolsma MF
Biochem Pharmacol; 1984 Mar; 33(5):763-70. PubMed ID: 6424679
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of adenosine deaminase-deficient human T cell lines.
Kohn DB; Mitsuya H; Ballow M; Selegue JE; Barankiewicz J; Cohen A; Gelfand E; Anderson WF; Blaese RM
J Immunol; 1989 Jun; 142(11):3971-7. PubMed ID: 2497184
[TBL] [Abstract][Full Text] [Related]
9. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
12. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
Webster AD; Ip H; Pereira S
Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
[TBL] [Abstract][Full Text] [Related]
13. Effects of deoxycoformycin in mice. II. Differences between the drug sensitivities and purine metabolizing enzymes of transplantable lymphomas of varying immunologic phenotypes.
Ratech H; Kim J; Asofsky R; Thorbecke GJ; Hirschhorn R
J Immunol; 1984 Jun; 132(6):3077-84. PubMed ID: 6202772
[TBL] [Abstract][Full Text] [Related]
14. Severe combined immunodeficiency in a child with a healthy adenosine deaminase deficient mother.
Schmalstieg FC; Mills GC; Tsuda H; Goldman AS
Pediatr Res; 1983 Dec; 17(12):935-40. PubMed ID: 6606796
[TBL] [Abstract][Full Text] [Related]
15. Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2'-deoxycoformycin, and adenosine deaminase inhibitor.
Ratech H; Thorbecke GJ; Hirschhorn R
Clin Immunol Immunopathol; 1981 Oct; 21(1):119-27. PubMed ID: 6268339
[No Abstract] [Full Text] [Related]
16. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
[No Abstract] [Full Text] [Related]
17. Importance of platelet-free preparations for evaluating lymphocyte nucleotide levels in inherited or acquired immunodeficiency syndromes.
Goday A; Simmonds HA; Webster DR; Levinsky RJ; Watson AR; Hoffbrand AV
Clin Sci (Lond); 1983 Dec; 65(6):635-43. PubMed ID: 6414755
[TBL] [Abstract][Full Text] [Related]
18. ATP depletion as a consequence of adenosine deaminase inhibition in man.
Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
[TBL] [Abstract][Full Text] [Related]
20. Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.
Van De Wiele CJ; Vaughn JG; Blackburn MR; Ledent CA; Jacobson M; Jiang H; Thompson LF
J Clin Invest; 2002 Aug; 110(3):395-402. PubMed ID: 12163459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
